Developments NeuroThera expands IP portfolio through collaboration with Clearmind NeuroThera Labs (TSXV: NTLX) has highlighted the expansion of the U.S. intellectual property (IP) portfolio through its ongoing collaboration with Clearmind Medicine (NASDAQ: CMND). As part of the collaboration, three U... September 24, 2026